Organization · Venture Studio
MINT Venture Partners
MINT Venture Partners is a South Korean venture studio focused on creating, building, and investing in biotech and healthcare startups. It operates as an integrated platform that combines discovery, incubation, acceleration, and investment.
Overview
What MINT Venture Partners does
What MINT Venture Partners is
MINT Venture Partners is a South Korean venture studio focused on creating, building, and investing in biotech and healthcare startups. It operates as an integrated platform that combines discovery, incubation, acceleration, and investment.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 25, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find MINT Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
MINT Venture Partners as a funder
Investment thesis
MINT Venture Partners focuses on building, accelerating, and investing in biotech and healthcare startups, partnering with visionary founders to create impactful businesses.
Focus narrative
MINT Venture Partners invests in the biotech and healthcare sectors, emphasizing innovative technologies and solutions that advance medicine. Their investment strategy encompasses startup creation through programs like PRISM and CUBE, as well as growth acceleration via Mint MD and Mint MedTech, engaging in various stages of company development from initial concept to scaling operations.
Value beyond capital
MINT Venture Partners adds value to its portfolio companies through a comprehensive support system that includes access to specialized programs for drug discovery, incubation, and acceleration. Their expertise in biotech and healthcare, combined with a strong network of industry professionals, enables them to guide startups from concept to commercialization effectively.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · AI · Medical Devices
- Regions
- Global · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
MINT Venture Partners has a diverse portfolio that includes notable projects such as Senda Biosciences, which focuses on microbiome-based therapeutics, and various innovative technologies including novel ADC therapeutics for cancers, regenerative therapeutics using organoids, and AI-powered solutions for medical diagnostics.
Capability profile
MINT Venture Partners as a program host
Program thesis
MINT Venture Partners is a global venture platform focused on creating, building, accelerating, and investing in biotech and healthcare startups.
Focus narrative
MINT Venture Partners focuses on investing in innovative technologies within the biotech and healthcare sectors. Their investment philosophy encompasses drug and treatment development, diagnostic advancements, digital healthcare solutions, and wellness innovations. They support startups that are pioneering small molecules, antibody therapies, AI-driven diagnostics, and personalized health management solutions.
Value and support
MINT Venture Partners offers a range of support programs for startups, including mentorship, strategic investments, and access to a network of healthcare professionals. Their programs, such as Mint Stetho and PRISM, provide resources for discovery, business planning, and growth acceleration.
Additional public guidance
Q: What types of startups does MINT Venture Partners support? A: MINT focuses on biotech and healthcare startups, particularly those innovating in drug development, diagnostics, and digital healthcare solutions. Q: How can startups apply for support? A: Startups can apply through the MINT Venture Partners website.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Global · Asia · North America
Alumni and track record
Alumni context
MINT Venture Partners has invested in several notable companies, including Aimedbio, which develops novel ADC therapies for cancer; OrganoidRx, focusing on regenerative medicine; Hyperfine, creator of the world's first portable MRI; and Charco Neurotech, which develops devices for treating motor disorders in Parkinson's disease.
Common questions
What to know about MINT Venture Partners
Upseed classifies MINT Venture Partners under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.